Evidence map›Paper›PMID 22333735›Full record

ReviewCell cycle (Georgetown, Tex.)2012

The role of TRADD in death receptor signaling.

Yelena L Pobezinskaya, Zhenggang Liu

Open access · bronzeAbstract readReview
In one paragraph

Review in Cell cycle (Georgetown, Tex.), 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 77 papers.

0numbers the graph read from it
0cells of the map it votes in
77citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

77 citing papers in PubMed, 153 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. TNF-alpha: Roles in pathogenesis and therapeutics in cancer.The Journal of biological chemistry · 2026
    Review
  5. Article
  6. Article
  7. CD95/Fas stoichiometry in future precision medicine.Cell death and differentiation · 2025
    Review
  8. Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Review
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. [Recent research on the role of oxidative stress in the pathogenesis of attention deficit hyperactivity disorder].Zhongguo dang dai er ke za zhi = Chinese journal of contemporary pediatrics · 2024
    Review
  20. Role of TNFPain research & management · 2024
    Review

17 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 1 country.

Yelena L PobezinskayaCell and Cancer Biology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.
Zhenggang Liu
Center for Cancer Research · USNational Institutes of Health · US

Funding

TNF Signaling, Cell Death and CancerZIASC010376 · NCI · DIVISION OF CLINICAL SCIENCES - NCI · PI LIU, ZHENG-GANG · 2009 to 2025
$22.1M
The Molecular Mechanism of TNF-induced Necrotic Cell DeathZIABC010783 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI LIU, ZHENG-GANG · 2009 to 2025
$9.5M
6 · The paper itself

Abstract

TRADD (TNFR1-associated death domain protein) was initially identified as an adaptor molecule that transduces the signal downstream of the TNFR1 (tumor necrosis factor receptor 1). TNFR1 belongs to the so-called death receptor (DR) family of receptors that depending on the context can induce either apoptosis or proliferation, as well as NF-κB and MAP kinase activation. The receptors of this group contain death domain (DD) that is necessary for the induction of apoptosis. This review summarizes the recent advances in the field of DR signaling and in particular the role of TRADD.

Indexed as

ApoptosisHumansMitogen-Activated Protein KinasesNF-kappa BReceptors, Death DomainReceptors, TNF-Related Apoptosis-Inducing LigandReceptors, Tumor Necrosis Factor, Type ISignal TransductionTNF Receptor-Associated Death Domain ProteinTNF-Related Apoptosis-Inducing LigandTumor Necrosis Factor Ligand Superfamily Member 15Mitogen-Activated Protein KinasesNF-kappa BReceptors, Death DomainReceptors, TNF-Related Apoptosis-Inducing LigandReceptors, Tumor Necrosis Factor, Type ITNF Receptor-Associated Death Domain ProteinTNF-Related Apoptosis-Inducing LigandTNFSF15 protein, humanTumor Necrosis Factor Ligand Superfamily Member 15

Identifiers

PMID22333735
PMCPMC3679287
OpenAlexW2026003504

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.